Literature DB >> 7103452

In vitro potentiation of cephalosporins by alafosfalin against urinary tract bacteria.

M Arisawa, J Ohshima, E Ohsawa, H B Maruyama.   

Abstract

Potentiating activity of alafosfalin was examined in detail with 8 cephalosporins and mecillinam against 164 urinary bacteria representing 8 genera. Alafosfalin was generally comparable in activity to cefamandole and mecillinam but superior to other cephalosporins tested. When the minimal fractional inhibitory concentration indices were compared, synergism was observed with all of the beta-lactams tested for all species except Streptococcus faecalis. Marked synergism was observed with Escherichia coli, Citrobacter, and enterobacter and, among the drugs tested, with cefamandole and mecillinam. Although alafosfalin is inactive against Pseudomonas aeruginosa, potentiation was seen with cefsulodin. The most favorable combination ratio of alafosfalin/cephalosporin to elicit potentiation was determined for each species and occurred in a rather narrow range of combinations (1:4 to 4:1 in general).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7103452      PMCID: PMC181997          DOI: 10.1128/AAC.21.5.706

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  5 in total

1.  Phosphonopeptides, a new class of synthetic antibacterial agents.

Authors:  J G Allen; F R Atherton; M J Hall; C H Hassall; S W Holmes; R W Lambert; L J Nisbet; P S Ringrose
Journal:  Nature       Date:  1978-03-02       Impact factor: 49.962

2.  Semisynthetic beta-lactam antibiotics. 6. 1 Sulfocephalosporins and their antipseudomonal activities.

Authors:  H Nomura; T Fugono; T Hitaka; I Minami; T Azuma; S Morimoto; T Masuda
Journal:  J Med Chem       Date:  1974-12       Impact factor: 7.446

3.  Phosphonopeptides as antibacterial agents: metabolism and pharmacokinetics of alafosfalin in animals and humans.

Authors:  J G Allen; L Havas; E Leicht; I Lenox-Smith; L J Nisbet
Journal:  Antimicrob Agents Chemother       Date:  1979-09       Impact factor: 5.191

4.  Antibacterial properties of alafosfalin combined with cephalexin.

Authors:  F R Atherton; M J Hall; C H Hassall; S W Holmes; R W Lambert; W J Lloyd; L J Nisbet; P S Ringrose; D Westmacott
Journal:  Antimicrob Agents Chemother       Date:  1981-10       Impact factor: 5.191

5.  Alafosfalin, a new inhibitor of cell wall biosynthesis: in vitro activity against urinary isolates in Japan and potentiation with beta-lactams.

Authors:  H B Maruyama; M Arisawa; T Sawada
Journal:  Antimicrob Agents Chemother       Date:  1979-10       Impact factor: 5.191

  5 in total
  1 in total

1.  Phosphonopeptides Revisited, in an Era of Increasing Antimicrobial Resistance.

Authors:  Emma C L Marrs; Linda Varadi; Alexandre F Bedernjak; Kathryn M Day; Mark Gray; Amanda L Jones; Stephen P Cummings; Rosaleen J Anderson; John D Perry
Journal:  Molecules       Date:  2020-03-23       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.